Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01262027
Title TKI258 for Metastatic Inflammatory Breast Cancer Patients
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center|Novartis
Indications

Her2-receptor negative breast cancer

breast cancer

Therapies

Dovitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field